PMID- 17767807 OWN - NLM STAT- MEDLINE DCOM- 20080620 LR - 20131121 IS - 0161-6412 (Print) IS - 0161-6412 (Linking) VI - 30 IP - 1 DP - 2008 Feb TI - Pergolide protects CA1 neurons from apoptosis in a gerbil model of global cerebral ischemia. PG - 92-8 AB - OBJECTIVE: To investigate the effects of dopamine (DA) receptor agonists and antagonists on neuronal apoptosis in hippocampal CA1 region after forebrain ischemia/reperfusion (I/R) injury in gerbils. METHODS: Gerbil forebrain ischemia was induced by occluding bilateral carotid arteries for 5 minutes. The open field test, hematoxylin-eosin staining and in situ terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) methods were used 1, 3 and 7 days after reperfusion. Western blot was used to examine the phosphorylation of c-Jun. RESULTS: Pergolide could significantly reduce the habituation impairments of ischemic gerbils, increase the number of normal neurons and reduce the number of apoptotic neurons in hippocampal CA1 region after reperfusion. SKF38393, SCH23390 and spiperone had no effects on these changes in this transient I/R injury model. Furthermore, pergolide can significantly reduce the phosphorylation of c-Jun induced by transient forebrain ischemia. FAU - Zong, Xue-Mei AU - Zong XM AD - Center of Emergency, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China. FAU - Sun, Ya-Feng AU - Sun YF FAU - Pei, Dong-Sheng AU - Pei DS FAU - Zeng, Yin-Ming AU - Zeng YM FAU - Xu, Tie AU - Xu T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Neurol Res JT - Neurological research JID - 7905298 RN - 0 (Dopamine Agonists) RN - 0 (Proto-Oncogene Proteins c-jun) RN - 24MJ822NZ9 (Pergolide) SB - IM MH - Analysis of Variance MH - Animals MH - Apoptosis/*drug effects MH - Behavior, Animal/drug effects MH - *Brain Ischemia/drug therapy/pathology/physiopathology MH - Disease Models, Animal MH - Dopamine Agonists/*therapeutic use MH - Exploratory Behavior/drug effects MH - Gerbillinae MH - Hippocampus/*pathology MH - In Situ Nick-End Labeling/methods MH - Male MH - Neurons/*drug effects MH - Pergolide/*therapeutic use MH - Proto-Oncogene Proteins c-jun/metabolism MH - Time Factors EDAT- 2007/09/05 09:00 MHDA- 2008/06/21 09:00 CRDT- 2007/09/05 09:00 PHST- 2007/09/05 09:00 [pubmed] PHST- 2008/06/21 09:00 [medline] PHST- 2007/09/05 09:00 [entrez] AID - 10.1179/016164107X228688 [doi] PST - ppublish SO - Neurol Res. 2008 Feb;30(1):92-8. doi: 10.1179/016164107X228688.